[go: up one dir, main page]

DE60331319D1 - Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen - Google Patents

Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen

Info

Publication number
DE60331319D1
DE60331319D1 DE60331319T DE60331319T DE60331319D1 DE 60331319 D1 DE60331319 D1 DE 60331319D1 DE 60331319 T DE60331319 T DE 60331319T DE 60331319 T DE60331319 T DE 60331319T DE 60331319 D1 DE60331319 D1 DE 60331319D1
Authority
DE
Germany
Prior art keywords
composition
nutritional
organisms
increasing
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331319T
Other languages
English (en)
Inventor
Robert Johan Hageman
George Verlaan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Application granted granted Critical
Publication of DE60331319D1 publication Critical patent/DE60331319D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60331319T 2002-06-19 2003-06-19 Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen Expired - Lifetime DE60331319D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077434 2002-06-19
PCT/NL2003/000448 WO2004000297A1 (en) 2002-06-19 2003-06-19 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms

Publications (1)

Publication Number Publication Date
DE60331319D1 true DE60331319D1 (de) 2010-04-01

Family

ID=29797210

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331319T Expired - Lifetime DE60331319D1 (de) 2002-06-19 2003-06-19 Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen

Country Status (7)

Country Link
US (1) US20050287204A1 (de)
EP (1) EP1536781B1 (de)
AT (1) ATE457726T1 (de)
AU (1) AU2003247224A1 (de)
DE (1) DE60331319D1 (de)
ES (1) ES2341538T3 (de)
WO (1) WO2004000297A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US7785619B2 (en) 2004-04-08 2010-08-31 Micro Nutrient, Llc Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
US20050226906A1 (en) * 2004-04-08 2005-10-13 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US7850987B2 (en) 2004-04-08 2010-12-14 Micronutrient, Llc Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
ATE381892T1 (de) 2004-06-09 2008-01-15 Evonik Degussa Gmbh Guanidinoessigsäure als futtermittelzusatz
DE102005009990A1 (de) * 2005-03-04 2006-09-07 Degussa Ag Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
US8536222B2 (en) 2005-03-04 2013-09-17 Alzchem Ag Addition compounds of guanidinoacetic acid
CN101267746A (zh) * 2005-08-02 2008-09-17 澳泽化学特罗斯特贝格有限公司 基于胍基乙酸成分的液体制剂
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
DE102006009373A1 (de) * 2006-03-01 2007-09-06 Degussa Gmbh Fertigfutter für Haustiere
DE102007004781A1 (de) 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US8173181B2 (en) * 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism
CA2855854C (en) * 2011-11-21 2020-03-31 The Institute For Ethnomedicine L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
WO2015003021A2 (en) * 2013-07-01 2015-01-08 The Trustees Of Princeton University Dietary supplements and composition for treating cancer
KR20160137528A (ko) 2014-02-07 2016-11-30 유니버시티 오브 유타 리서치 파운데이션 크레아틴, 오메가-3 지방산 및 시티콜린의 조합
CA3052324C (en) * 2017-03-03 2020-11-03 Exerkine Corporation Multi-nutrient composition
KR102022118B1 (ko) * 2019-01-07 2019-09-18 주식회사 아스트로젠 중추신경계 질환의 예방 또는 치료용 세린 유도체 화합물
EP4017278A4 (de) 2019-08-21 2023-09-13 Brain Chemistry Labs Zusammensetzungen mit metall und l-serin und verwendungen davon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB696405A (en) * 1950-12-15 1953-08-26 California Inst Res Found Improvements in or relating to preparations for muscular and nervous disorders and method of preparing the same
US2761807A (en) * 1955-05-16 1956-09-04 California Inst Res Found Glycocyamine and methylating agent in vivo creatine producing composition
FR2218883B1 (de) * 1973-02-28 1976-08-13 Science Union & Cie
US4582807A (en) * 1982-07-30 1986-04-15 Natteri Veeraraghavan Cultivation medium for mycobacteria and use thereof
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
AP387A (en) * 1991-09-13 1995-07-31 Siegbert Heinrich Bissbort Therapeutical uses of L-methionine and compositions thereof.
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
US6727285B1 (en) * 1995-11-07 2004-04-27 George M. Haik, Jr. Use of D-arginine and/or L-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls
EP0891719A1 (de) * 1997-07-14 1999-01-20 N.V. Nutricia Narungszusammensetzungen mit Gehalt an Methionin
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6172114B1 (en) * 1999-09-30 2001-01-09 Worldwide Sports Nutritional Supplements, Inc. Creatine supplement

Also Published As

Publication number Publication date
WO2004000297A1 (en) 2003-12-31
EP1536781B1 (de) 2010-02-17
AU2003247224A1 (en) 2004-01-06
EP1536781A1 (de) 2005-06-08
ES2341538T3 (es) 2010-06-22
ATE457726T1 (de) 2010-03-15
US20050287204A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
DE60331319D1 (de) Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
EA200300994A1 (ru) Композиция, исправляющая возрастные физиологические дефициты и увеличивающая продолжительность жизни
BR9910296A (pt) Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado
ES2181234T3 (es) Producto de combinacion que asocia un acido nucleico a una sustancia que desorganiza la matriz extracelular para la terapia genica.
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
TR200202175T1 (tr) Hücrelerin biyoenerji metabolizmasında bulunan biyokimyasal bileşiklerin kompozisyonları
BRPI0314666B8 (pt) composição nutricional ou terapêutica utilizável para o tratamento de mamíferos para aumentar a atividade imune
MY166631A (en) Orally administrable composition for improving skin quality
MXPA05002651A (es) Composicion oralmente administrable para mejorar la calidad del cabello y del pelo.
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
TWI319399B (en) Biguanide and dihydrotriazine derivatives
BRPI0417093A (pt) composição para consumo animal, método para aumentar a palatabilidade de uma composição de ração, método para aumentar a ingestão de uma ração por um animal, processo para a preparação de uma composição para consumo animal, e, refeição e brinquedo para animal
TW200605786A (en) Dermally applicable liquid formulations for controlling parasitic arthropods on animals
AU4263696A (en) Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
AU3042497A (en) Vaccine containing a peroxiredoxin and/or a beta-tubulin
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
EP1186292A3 (de) Feste Zubereitungen mit einer Multi-Kern Struktur
EP1572086A4 (de) Verfahren und zusammensetzung auf basis der entdeckung des stoffwechsels von nitroglycerin
TW200514507A (en) Active compound combinations having insecticidal and acaricidal properties
DE60140964D1 (en) Sphingolipiden
DE69812438D1 (de) Zusammensetzung zur herstellung von brennstoff-briketts
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання

Legal Events

Date Code Title Description
8364 No opposition during term of opposition